Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence

@article{Jensen2015MedicalMA,
  title={Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence},
  author={Bj{\o}rn Jensen and Jeffrey Chen and T. Furnish and M. Wallace},
  journal={Current Pain and Headache Reports},
  year={2015},
  volume={19},
  pages={1-9}
}
Cannabinoid compounds include phytocannabinoids, endocannabinoids, and synthetics. The two primary phytocannabinoids are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), with CB1 receptors in the brain and peripheral tissue and CB2 receptors in the immune and hematopoietic systems. The route of delivery of cannabis is important as the bioavailability and metabolism are very different for smoking versus oral/sublingual routes. Gold standard clinical trials are limited; however, some… Expand

Paper Mentions

Interventional Clinical Trial
As medical cannabis use becomes more common in the United States, it is essential to understand the ways in which adults who use medical cannabis perceive the benefits of… Expand
ConditionsCannabis Use, Insomnia Chronic
InterventionBehavioral
News Article
Cannabinoids in Pain Treatment: An Overview.
Tetrahydrocannabinol – friend or foe? – Debate
Medical Cannabis for Neuropathic Pain
Cannabis and cannabidiol (CBD) for the treatment of fibromyalgia.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 102 REFERENCES
Cannabidiol: An Overview of Some Pharmacological Aspects
Cannabinoid pharmacology: the first 66 years
  • R. Pertwee
  • Medicine
  • British journal of pharmacology
  • 2006
Effects of nabilone, a synthetic cannabinoid, on postoperative pain
  • P. Beaulieu
  • Medicine
  • Canadian journal of anaesthesia = Journal canadien d'anesthesie
  • 2006
Cannabinoids and neuroinflammation
...
1
2
3
4
5
...